Charlotte Simmler

Dr. Charlotte Simmler

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 October 2014 in Journal of Medicinal Chemistry
Verified
Journal Article
Open access
GPGuido F. Pauli
Guido F. Pauli
SCShao-Nong Chen
Shao-Nong Chen
CSCharlotte Simmler
Charlotte Simmler
DLDavid C. Lankin
David C. Lankin
TGTanja Gödecke
Tanja Gödecke
JNJosé G. Napolitano
José G. Napolitano
In any biomedical and chemical context, a truthful description of chemical constitution requires coverage of both structure and purity. This qualification affects all drug molecules, regardless of development stage (early discovery to approved drug) and source (natural product or synthetic). Purity assessment is particularly critical in discovery programs and whenever chemistry is linked with biological and/or therapeutic outcome. Compared with chromatography and elemental analysis, quantitative NMR (qNMR) uses nearly universal detection and provides a versatile and orthogonal means of purity evaluation. Absolute qNMR with flexible calibration captures analytes that frequently escape detection (water, sorbents). Widely accepted structural NMR workflows require minimal or no adjustments to become practical 1H qNMR (qHNMR) procedures with simultaneous qualitative and (absolute) quantitative capability. This study reviews underlying concepts, provides a framework for standard qHNMR purity assays, and shows how adequate accuracy and precision are achieved for the intended use of the material.

1 February 2014 in Current Opinion in Biotechnology
Verified
Journal Article
Closed access
CSCharlotte Simmler
Charlotte Simmler
JNJosé G Napolitano
José G Napolitano
JMJames B McAlpine
James B McAlpine
SCShao-Nong Chen
Shao-Nong Chen
GPGuido F Pauli
Guido F Pauli

1 October 2013 in Fitoterapia
Verified
Journal Article
Closed access
CSCharlotte Simmler
Charlotte Simmler
GPGuido F. Pauli
Guido F. Pauli
SCShao-Nong Chen
Shao-Nong Chen

8 August 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
AJAsha Jaja-Chimedza
Asha Jaja-Chimedza
BGBrittany L Graf
Brittany L Graf
CSCharlotte Simmler
Charlotte Simmler
YKYoujin Kim
Youjin Kim
PKPeter Kuhn
Peter Kuhn
IRIlya Raskin
Ilya Raskin
Moringa oleifera Lam. is a tropical plant, used for centuries as food and traditional medicine. The aim of this study was to develop, validate and biochemically characterize an isothiocyanate-enriched moringa seed extract (MSE), and to compare the anti-inflammatory effects of MSE-containing moringa isothiocyanate-1 (MIC-1) with a curcuminoid-enriched turmeric extract (CTE), and a material further enriched in its primary phytochemical, curcumin (curcumin-enriched material; CEM). MSE was prepared by incubating ground moringa seeds with water to allow myrosinase-catalyzed enzymatic formation of bioactive MIC-1, the predominant isothiocyanate in moringa seeds. Optimization of the extraction process yielded an extract of 38.9% MIC-1. Phytochemical analysis of MSE revealed the presence of acetylated isothiocyanates, phenolic glycosides unique to moringa, flavonoids, fats and fatty acids, proteins and carbohydrates. MSE showed a reduction in the carrageenan-induced rat paw edema (33% at 500 mg/kg MIC-1) comparable to aspirin (27% at 300 mg/kg), whereas CTE did not have any significant effect. In vitro, MIC-1 at 1 μM significantly reduced the production of nitric oxide (NO) and at 5 μM, the gene expression of LPS-inducible nitric oxide synthase (iNOS) and interleukins 1β and 6 (IL-1β and IL-6), whereas CEM did not show any significant activity at all concentrations tested. MIC-1 (10μM) was also more effective at upregulating the nuclear factor (erythroid-derived 2)-like 2 (Nrf2) target genes NAD(P)H:quinone oxidoreductase 1 (NQO1), glutathione S-transferase pi 1 (GSTP1), and heme oxygenase 1 (HO1) than the CEM. Thus, in contrast to CTE and CEM, MSE and its major isothiocyanate MIC-1 displayed strong anti-inflammatory and antioxidant properties in vivo and in vitro, making them promising botanical leads for the mitigation of inflammatory-mediated chronic disorders.

13 July 2018 in Natural Product Reports
Verified
Journal Article
Open access
PDF file
JMJames B. McAlpine
James B. McAlpine
SCShao-Nong Chen
Shao-Nong Chen
AKAndrei G. Kutateladze
Andrei G. Kutateladze
JMJohn B MacMillan
John B MacMillan
Giovanni AppendinoGiovanni Appendino
Giovanni Appendino
GPGuido F. Pauli
Guido F. Pauli
With contributions from the global natural product (NP) research community, and continuing the Raw Data Initiative, this review collects a comprehensive demonstration of the immense scientific value of disseminating raw nuclear magnetic resonance (NMR) data, independently of, and in parallel with, classical publishing outlets.

12 July 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
AHAtieh A Hajirahimkhan
Atieh A Hajirahimkhan
CSCharlotte Simmler
Charlotte Simmler
YYYang Yuan
Yang Yuan
JAJeffrey R. Anderson
Jeffrey R. Anderson
SCShao-Nong Chen
Shao-Nong Chen
JBJudy L. Bolton
Judy L. Bolton
The increased cancer risk associated with hormone therapies has encouraged many women to seek non-hormonal alternatives including botanical supplements such as hops (Humulus lupulus) and licorice (Glycyrrhiza spec.) to manage menopausal symptoms. Previous studies have shown estrogenic properties for hops, likely due to the presence of 8-prenylnarigenin, and chemopreventive effects mainly attributed to xanthohumol. Similarly, a combination of estrogenic and chemopreventive properties has been reported for various Glycyrrhiza species. The major goal of the current study was to evaluate the potential estrogenic effects of three licorice species (Glycyrrhiza glabra, G. uralensis, and G. inflata) in comparison with hops. Extracts of Glycyrrhiza species and spent hops induced estrogen responsive alkaline phosphatase activity in endometrial cancer cells, estrogen responsive element (ERE)-luciferase in MCF-7 cells, and Tff1 mRNA in T47D cells. The estrogenic activity decreased in the order H. lupulus > G. uralensis > G. inflata > G. glabra. Liquiritigenin was found to be the principle phytoestrogen of the licorice extracts; however, it exhibited lower estrogenic effects compared to 8-prenylnaringenin in functional assays. Isoliquiritigenin, the precursor chalcone of liquiritigenin, demonstrated significant estrogenic activities while xanthohumol, a metabolic precursor of 8-prenylnaringenin, was not estrogenic. Liquiritigenin showed ERβ selectivity in competitive binding assay and isoliquiritigenin was equipotent for ER subtypes. The estrogenic activity of isoliquiritigenin could be the result of its cyclization to liquiritigenin under physiological conditions. 8-Prenylnaringenin had nanomolar estrogenic potency without ER selectivity while xanthohumol did not bind ERs. These data demonstrated that Glycyrrhiza species with different contents of liquiritigenin have various levels of estrogenic activities, suggesting the importance of precise labeling of botanical supplements. Although hops shows strong estrogenic properties via ERα, licorice might have different estrogenic activities due to its ERβ selectivity, partial estrogen agonist activity, and non-enzymatic conversion of isoliquiritigenin to liquiritigenin.